Literature DB >> 35294707

A Decentralized Model for Supervised Consumption Services.

Hannan M Braun1,2, Josiah D Rich3,4.   

Abstract

Entities:  

Year:  2022        PMID： 35294707      PMCID： PMC9033915          DOI： 10.1007/s11524-022-00621-x

Source DB:  PubMed          Journal:  J Urban Health        ISSN： 1099-3460            Impact factor:   5.801


× No keyword cloud information.
  9 in total

1.  Rate of detoxification service use and its impact among a cohort of supervised injecting facility users.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Julio S G Montaner; Thomas Kerr
Journal:  Addiction       Date:  2007-06       Impact factor: 6.526

2.  Evaluation of an Unsanctioned Safe Consumption Site in the United States.

Authors:  Alex H Kral; Barrot H Lambdin; Lynn D Wenger; Pete J Davidson
Journal:  N Engl J Med       Date:  2020-07-08       Impact factor: 91.245

3.  Impact of an unsanctioned safe consumption site on criminal activity, 2010-2019.

Authors:  Peter J Davidson; Barrot H Lambdin; Erica N Browne; Lynn D Wenger; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2021-01-11       Impact factor: 4.492

4.  Addressing the Nation's Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S.

Authors:  Alex H Kral; Peter J Davidson
Journal:  Am J Prev Med       Date:  2017-08-08       Impact factor: 5.043

5.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.

Authors:  Czarina N Behrends; Denise Paone; Michelle L Nolan; Ellenie Tuazon; Sean M Murphy; Shashi N Kapadia; Philip J Jeng; Ahmed M Bayoumi; Hillary V Kunins; Bruce R Schackman
Journal:  J Subst Abuse Treat       Date:  2019-08-14

6.  High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.

Authors:  Allison M Salmon; Ingrid van Beek; Janaki Amin; Andrew Grulich; Lisa Maher
Journal:  Aust N Z J Public Health       Date:  2009-06       Impact factor: 2.939

7.  HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges.

Authors:  Sabrina A Assoumou; Samantha M Paniagua; Priscilla Gonzalez; Jianing Wang; Curt G Beckwith; Laura F White; Jessica L Taylor; Kristen Coogan; Jeffrey H Samet; Benjamin P Linas
Journal:  AIDS Behav       Date:  2021-03-22

8.  Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States.

Authors:  Barrot H Lambdin; Peter J Davidson; Erica N Browne; Leslie W Suen; Lynn D Wenger; Alex H Kral
Journal:  J Gen Intern Med       Date:  2022-01-12       Impact factor: 5.128

9.  Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  PLoS One       Date:  2008-10-07       Impact factor: 3.240
  9 in total
  1 in total

1.  Responding to a surge in overdose deaths: perspectives from US syringe services programs.

Authors:  Madeline C Frost; Elizabeth J Austin; Maria A Corcorran; Elsa S Briggs; Czarina N Behrends; Alexa M Juarez; Noah D Frank; Elise Healy; Stephanie M Prohaska; Paul A LaKosky; Shashi N Kapadia; David C Perlman; Bruce R Schackman; Don C Des Jarlais; Emily C Williams; Sara N Glick
Journal:  Harm Reduct J       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.